Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Sage Therapeutics Gross Profit 2013-2024 | SAGE

Sage Therapeutics gross profit from 2013 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Sage Therapeutics Annual Gross Profit
(Millions of US $)
2023 $84
2022 $7
2021 $6
2020 $1,114
2019 $6
2018 $90
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
Sage Therapeutics Quarterly Gross Profit
(Millions of US $)
2024-03-31 $7
2023-12-31 $77
2023-09-30 $2
2023-06-30 $2
2023-03-31 $3
2022-12-31 $3
2022-09-30 $2
2022-06-30 $1
2022-03-31 $1
2021-12-31 $2
2021-09-30 $1
2021-06-30 $1
2021-03-31 $1
2020-12-31 $1,109
2020-09-30 $1
2020-06-30 $1
2020-03-31 $2
2019-12-31 $2
2019-09-30 $3
2019-06-30 $1
2019-03-31 $0
2018-12-31 $0
2018-09-30
2018-06-30 $90
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.656B $0.086B
SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product candidates include SAGE-547, SAGE-689 and SAGE-217. SAGE Therapeutics, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.648B 31.17
Chugai Pharmaceutical (CHGCY) Japan $57.871B 25.87
Takeda Pharmaceutical (TAK) Japan $41.080B 8.32
Merck (MKGAF) Germany $21.118B 20.48
Astellas Pharma (ALPMY) Japan $17.771B 28.06
Sandoz Group AG (SDZNY) Switzerland $15.585B 0.00
United Therapeutics (UTHR) United States $14.151B 15.09
Neurocrine Biosciences (NBIX) United States $13.594B 37.21
Shionogi (SGIOY) Japan $11.423B 9.93
Catalent (CTLT) United States $10.160B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.208B 0.00
Ionis Pharmaceuticals (IONS) United States $6.860B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.816B 7.49
Revolution Medicines (RVMD) United States $6.406B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.968B 0.00
Summit Therapeutics (SMMT) United States $5.623B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.538B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.337B 0.00
Corcept Therapeutics (CORT) United States $3.164B 28.67
Dyne Therapeutics (DYN) United States $2.963B 0.00
PTC Therapeutics (PTCT) United States $2.696B 0.00
Indivior (INDV) United States $2.245B 10.64
Recursion Pharmaceuticals (RXRX) United States $2.229B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.006B 11.40
Catalyst Pharmaceuticals (CPRX) United States $1.789B 17.41
NewAmsterdam Pharma (NAMS) Netherlands $1.770B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.615B 24.28
Ardelyx (ARDX) United States $1.401B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.374B 0.00
Pacira BioSciences (PCRX) United States $1.321B 12.56
Soleno Therapeutics (SLNO) United States $1.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.255B 0.00
Xencor (XNCR) United States $1.193B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.157B 0.00
4D Molecular Therapeutics (FDMT) United States $1.137B 0.00
Collegium Pharmaceutical (COLL) United States $1.031B 6.17
Ocular Therapeutix (OCUL) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.010B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.966B 15.05
Cassava Sciences (SAVA) United States $0.925B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.893B 0.00
Cronos Group (CRON) Canada $0.867B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.795B 0.00
Harrow (HROW) United States $0.766B 0.00
ARS Pharmaceuticals (SPRY) United States $0.741B 0.00
Exscientia (EXAI) United Kingdom $0.639B 0.00
Silence Therapeutics (SLN) United Kingdom $0.597B 0.00
Lexeo Therapeutics (LXEO) United States $0.556B 0.00
Altimmune (ALT) United States $0.525B 0.00
Savara (SVRA) United States $0.525B 0.00
Siga Technologies (SIGA) United States $0.524B 6.70
Lyell Immunopharma (LYEL) United States $0.520B 0.00
ProKidney (PROK) United States $0.511B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Heron Therapeutics (HRTX) United States $0.459B 0.00
Larimar Therapeutics (LRMR) United States $0.449B 0.00
OmniAb (OABI) United States $0.446B 0.00
Verve Therapeutics (VERV) United States $0.439B 0.00
Bioventus (BVS) United States $0.434B 16.61
Theravance Biopharma (TBPH) Cayman Islands $0.409B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.364B 0.00
Organogenesis (ORGO) United States $0.331B 62.50
Xeris Biopharma Holdings (XERS) United States $0.311B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Century Therapeutics (IPSC) United States $0.216B 0.00
ESSA Pharma (EPIX) Canada $0.215B 0.00
Incannex Healthcare (IXHL) Australia $0.214B 0.00
Eliem Therapeutics (ELYM) United States $0.213B 0.00
Aquestive Therapeutics (AQST) United States $0.210B 0.00
Prelude Therapeutics (PRLD) United States $0.208B 0.00
Fractyl Health (GUTS) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Elite Pharmaceuticals (ELTP) United States $0.195B 18.28
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Acrivon Therapeutics (ACRV) United States $0.187B 0.00
Pyxis Oncology (PYXS) United States $0.180B 0.00
Akebia Therapeutics (AKBA) United States $0.180B 0.00
Adherex Technologies (FENC) United States $0.169B 206.67
Context Therapeutics (CNTX) United States $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.148B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.140B 0.00
Metagenomi (MGX) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.139B 0.00
CytoDyn (CYDY) United States $0.137B 0.00
Karyopharm Therapeutics (KPTI) United States $0.136B 0.00
MediWound (MDWD) Israel $0.136B 0.00
Telomir Pharmaceuticals (TELO) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.126B 8.41
VAXART, INC (VXRT) United States $0.122B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.114B 5.22
Journey Medical (DERM) United States $0.100B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Conduit Pharmaceuticals (CDT) United States $0.091B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
ProPhase Labs (PRPH) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.01
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Carisma Therapeutics (CARM) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
SHINECO (SISI) China $0.024B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 29.19